Mydriasis in a Parkinson's disease patient on low-dose carbidopa/levodopa

被引：0
|
作者：
Burdick, D. J.
Griffith, A.
Cole, A.
Sia, C. M.
Agarwal, P.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
613
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [21] Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
    Hauser, Robert A.
    Panisset, Michel
    Abbruzzese, Giovanni
    Mancione, Linda
    Dronamraju, Nalina
    Kakarieka, Algirdas
    MOVEMENT DISORDERS, 2009, 24 (04) : 541 - 550
  • [22] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [23] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
    Francesc Valldeoriola
    María José Catalán
    Francisco Escamilla-Sevilla
    Eric Freire
    Jesús Olivares
    Esther Cubo
    Diego Santos García
    Matilde Calopa
    Pablo Martínez-Martín
    Juan Carlos Parra
    Gloria Arroyo
    José Matías Arbelo
    npj Parkinson's Disease, 7
  • [24] Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient
    Solla, Paolo
    Cannas, Antonino
    Congia, Socrate
    Floris, Gianluca
    Aste, Rosa
    Tacconi, Paolo
    Marrosu, Maria Giovanna
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 154 - 156
  • [25] Plasma levodopa level treated with levodopa in combination with carbidopa or benserazide in Parkinson's disease
    Nomoto, M
    Nagai, M
    Yabe, H
    Nakatsuka, A
    Moritoyo, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 118P - 118P
  • [26] Improved symptom control with fixed dose levodopa/carbidopa/entacapone versus conventional levodopa/carbidopa as first-line levodopa therapy in early Parkinson's disease patients
    Hauser, R. A.
    Panisset, M.
    Abbruzzese, G.
    Mancione, L.
    Dronamraju, N.
    Kakarieka, A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S208 - S208
  • [27] Improved symptom control with fixed dose levodopa/carbidopa/entacapone versus levodopa/carbidopa as first-line levodopa therapy in early Parkinson's disease (PD) patients
    Hauser, Robert A.
    Panisset, Michel
    Abbruzzese, Giovanni
    Mancione, Linda
    Dronamraju, Nalina
    Kakarieka, Algirdas
    NEUROLOGY, 2008, 71 (02) : 154 - 154
  • [28] Levodopa half-life with additional carbidopa in Parkinson's disease (PD) patients treated with carbidopa/levodopa and entacapone
    Parashos, SA
    Wielinski, CL
    Peterson, SM
    Brundage, RC
    MOVEMENT DISORDERS, 2005, 20 : S89 - S90
  • [29] Extended-release carbidopa-levodopa in Parkinson's disease
    Rascol, Olivier
    LANCET NEUROLOGY, 2013, 12 (04): : 325 - 326
  • [30] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
12345